7.20
Precedente Chiudi:
$7.26
Aprire:
$7.19
Volume 24 ore:
2.39M
Relative Volume:
0.32
Capitalizzazione di mercato:
$1.14B
Reddito:
$2.59B
Utile/perdita netta:
$-981.73M
Rapporto P/E:
-1.2478
EPS:
-5.77
Flusso di cassa netto:
$206.95M
1 W Prestazione:
+5.42%
1M Prestazione:
-16.67%
6M Prestazione:
-15.99%
1 anno Prestazione:
-45.99%
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
2 MANHATTANVILLE ROAD, PURCHASE, NY
Confronta TDOC con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
TDOC
Teladoc Health Inc
|
7.20 | 1.14B | 2.59B | -981.73M | 206.95M | -5.77 |
![]()
VEEV
Veeva Systems Inc
|
227.54 | 34.18B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
56.65 | 9.62B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
52.90 | 7.09B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
85.87 | 6.94B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
37.02 | 6.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-11-15 | Iniziato | Goldman | Buy |
2024-09-17 | Reiterato | Jefferies | Hold |
2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
2024-02-26 | Iniziato | Leerink Partners | Market Perform |
2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
2024-01-03 | Iniziato | Barclays | Overweight |
2023-04-12 | Iniziato | Stephens | Equal-Weight |
2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2022-09-07 | Iniziato | Truist | Hold |
2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
2022-08-12 | Iniziato | DA Davidson | Buy |
2022-08-02 | Downgrade | Berenberg | Buy → Hold |
2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
2022-07-28 | Downgrade | Goldman | Buy → Neutral |
2022-07-28 | Downgrade | Needham | Buy → Hold |
2022-07-06 | Reiterato | BofA Securities | Neutral |
2022-05-05 | Downgrade | Argus | Buy → Hold |
2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
2022-04-07 | Iniziato | Guggenheim | Buy |
2022-04-01 | Ripresa | Credit Suisse | Outperform |
2022-03-03 | Aggiornamento | Argus | Hold → Buy |
2022-02-23 | Reiterato | BofA Securities | Neutral |
2022-02-23 | Reiterato | Craig Hallum | Hold |
2022-02-23 | Reiterato | Evercore ISI | In-line |
2022-02-23 | Reiterato | Goldman | Buy |
2022-02-23 | Reiterato | JP Morgan | Overweight |
2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
2022-02-23 | Reiterato | Needham | Buy |
2022-02-23 | Reiterato | Oppenheimer | Outperform |
2022-02-23 | Reiterato | Stifel | Hold |
2022-02-11 | Iniziato | Goldman | Buy |
2022-02-08 | Reiterato | Piper Sandler | Overweight |
2021-12-02 | Ripresa | Jefferies | Hold |
2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
2021-10-28 | Reiterato | Barclays | Equal Weight |
2021-10-28 | Reiterato | BofA Securities | Neutral |
2021-10-28 | Reiterato | Canaccord Genuity | Buy |
2021-10-28 | Reiterato | Citigroup | Buy |
2021-10-28 | Reiterato | Craig Hallum | Hold |
2021-10-28 | Reiterato | Needham | Buy |
2021-10-28 | Reiterato | Oppenheimer | Outperform |
2021-10-28 | Reiterato | Piper Sandler | Overweight |
2021-10-28 | Reiterato | UBS | Neutral |
2021-10-19 | Iniziato | Wells Fargo | Overweight |
2021-08-02 | Downgrade | Argus | Buy → Hold |
2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
2021-05-28 | Iniziato | Robert W. Baird | Neutral |
2021-04-15 | Iniziato | Needham | Buy |
2021-01-07 | Iniziato | BTIG Research | Buy |
2020-12-22 | Iniziato | Evercore ISI | In-line |
2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
2020-12-04 | Iniziato | Goldman | Neutral |
2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2020-09-22 | Iniziato | DA Davidson | Buy |
2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2020-07-14 | Iniziato | Citigroup | Buy |
2020-07-13 | Iniziato | Argus | Buy |
2020-07-07 | Iniziato | Stephens | Overweight |
2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
2020-04-13 | Iniziato | SVB Leerink | Outperform |
2020-03-31 | Downgrade | Berenberg | Buy → Hold |
2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2020-01-10 | Iniziato | UBS | Neutral |
2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Citi Revises Teladoc (TDOC) Price Target Amidst Cautious Outlook - GuruFocus
To Register Unwavering Growth Of Remote Medical Expert - openPR.com
Teladoc Health (NYSE:TDOC) Shares Fall 10% Over The Past Week - Yahoo Finance
Teladoc (TDOC) Experiences Surge in Bullish Option Activity | TDOC Stock News - GuruFocus
Digital Health In The Neurology Market Focusing On A Series - openPR.com
Chronic Disease Management Market Is Booming So Rapidly - openPR.com
U.S. Digital Mental Health Market New Product Development & Latest Trends | Teladoc Health,BetterHelp,Talkspace - openPR.com
Is Teladoc Health (TDOC) the Best Telehealth Stock to Buy Now? - Insider Monkey
Teladoc Health (TDOC) to Announce Q1 2025 Earnings on April 30 - GuruFocus
10 Best Telehealth Stocks to Buy Now - Insider Monkey
Jefferies cuts Teladoc price target to $8, maintains hold rating By Investing.com - Investing.com India
Jefferies cuts Teladoc price target to $8, maintains hold rating - Investing.com
Teladoc stock plunges to 52-week low, hits $6.61 By Investing.com - Investing.com India
Jefferies Lowers Teladoc (TDOC) Price Target Amid Declining Data Trends | TDOC Stock News - GuruFocus
Teladoc stock plunges to 52-week low, hits $6.61 - Investing.com
Emerging Trends in Telemedicine Second Opinion Solutions - openPR.com
Forecasting the Future: Healthcare Convenience Services - openPR.com
Telehealth Market Size to Reach USD 791.04 billion by 2032, Growing at CAGR of 22.9%NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Telestroke Services Market Set to Witness Significant Growth by 2025-2032 | ScienceSoft, SEVARO, Teladoc Health - openPR.com
Teladoc Health to Announce First Quarter 2025 Financial Results - GuruFocus
Teladoc Health to Announce First Quarter 2025 Financial Results | TDOC Stock News - GuruFocus
Teladoc Health Inc. to Release First Quarter 2025 Results on April 30, 2025 - Nasdaq
Virtual Care Leader Teladoc Health Sets Q1 2025 Earnings Release DateKey Details Inside - Stock Titan
Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade) (NYSE:TDOC) - Seeking Alpha
Emerging Trends in Video Consultation Medical Service Market - openPR.com
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it - TradingView
Future Scope of Virtual Healthcare Home Market to Observe - openPR.com
Virtual Care Services Market Projected To Witness Massive - openPR.com
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction - MSN
Teladoc (TDOC) Experiences Increased Option Activity Ahead of Ea - GuruFocus
BofA Revises Teladoc (TDOC) Price Target Amid Weaker Growth and Strategic Initiatives | TDOC Stock News - GuruFocus
Forecasting The Future: 8 Analyst Projections For Teladoc Health - Benzinga
Lobbying Update: $10,000 of TELADOC HEALTH INC. lobbying was just disclosed - Nasdaq
Teladoc Health Launches New Cardiometabolic Health Program - MedCity News
Unparalleled Research on Behavioral Health Telehealth Market - openPR.com
Digital Health Market Projected To Witness Substantial Growth, - openPR.com
Teladoc (TDOC) Stock Moves -0.97%: What You Should Know - Yahoo Finance
Teladoc Health CFO Murthy Mala sells $51,011 in stock By Investing.com - Investing.com South Africa
Teladoc Health CFO Murthy Mala sells $51,011 in stock - Investing.com
Trend Tracker for (TDOC) - news.stocktradersdaily.com
Teladoc unveils virtual care tool for cardiometabolic health - TechTarget
Digital health startup Transcarent takes Accolade private in $621 million deal - CNBC
Teladoc Health Introduces Next Generation Cardiometabolic Health Program - GlobeNewswire
Revolutionary: New Teladoc Health Program Achieves 58% Diabetes Remission Levels - Stock Titan
Teladoc Stock Plummets to 52-Week Low of $6.76 Amid Market Challenges - Investing.com India
Teladoc Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your Rights – TDOC - ACCESS Newswire
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? - AOL.com
Major Player in the Teletherapy Platform Integration Market - openPR.com
Teladoc (TDOC) Gains But Lags Market: What You Should Know - Yahoo Finance
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):